Virtus ETF Advisers’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-43,813
| Closed | -$795K | – | 370 |
|
|
2020
Q3 | $795K | Buy |
43,813
+3,690
| +9% | +$67K | 0.42% | 93 |
|
|
2020
Q2 | $550K | Buy |
40,123
+9,637
| +32% | +$132K | 0.26% | 135 |
|
|
2020
Q1 | $436K | Sell |
30,486
-2,573
| -8% | -$36.8K | 0.18% | 185 |
|
|
2019
Q4 | $560K | Buy |
33,059
+21,948
| +198% | +$372K | 0.09% | 196 |
|
|
2019
Q3 | $171K | Sell |
11,111
-619
| -5% | -$9.53K | 0.03% | 271 |
|
|
2019
Q2 | $275K | Buy |
11,730
+3,203
| +38% | +$75.1K | 0.06% | 255 |
|
|
2019
Q1 | $242K | Sell |
8,527
-1,083
| -11% | -$30.7K | 0.51% | 80 |
|
|
2018
Q4 | $290K | Sell |
9,610
-9,819
| -51% | -$296K | 0.05% | 122 |
|
|
2018
Q3 | $680K | Sell |
19,429
-13,886
| -42% | -$486K | 0.07% | 77 |
|
|
2018
Q2 | $790K | Sell |
33,315
-6,036
| -15% | -$143K | 0.7% | 36 |
|
|
2018
Q1 | $1.01M | Buy |
39,351
+21,280
| +118% | +$545K | 0.87% | 39 |
|
|
2017
Q4 | $314K | Buy |
+18,071
| New | +$314K | 0.39% | 118 |
|